Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
46.7%
% of MEDX's 30 holdings also in FTXH
28.0%
% of FTXH's 51 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.8% | 7.2% | 7.2% |
|
BRISTOL-MYERS SQUIBB CO | 5.3% | 7.4% | 5.3% |
|
JOHNSON & JOHNSON | 5.2% | 7.0% | 5.2% |
|
MERCK & CO. INC. | 5.2% | 7.6% | 5.2% |
|
PFIZER INC | 4.1% | 7.5% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to FTXH
|
ELI LILLY & CO | 11.2% |
 |
NOVARTIS AG-ADR | 5.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% |
|
CRISPR THERAPEUTICS AG | 3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
|
IONIS PHARMACEUTICALS, INC. | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
 |
ALKERMES PLC | 2.4% |
|
INTELLIA THERAPEUTICS, INC. | 1.9% |
|
AMGEN INC | 1.8% |
MEDX Underweight Relative to FTXH
|
CARDINAL HEALTH INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
VERTEX PHARMACEUTICALS INC | -3.6% |
|
GILEAD SCIENCES INC | -3.5% |
|
PFIZER INC | -3.4% |
|
VIATRIS, INC. | -3.2% |
|
JAZZ PHARMACEUTICALS PLC | -3.1% |
|
ZOETIS INC | -2.8% |
|
ORGANON & CO. | -2.7% |
|
MERCK & CO. INC. | -2.4% |